Exploring the Binding Site Crevice of a Family B G Protein-Coupled Receptor, the Type 1 Corticotropin Releasing Factor Receptor
Authors:
- Maria PapadokostakiMPMaria Papadokostaki
- Jonathan A. JavitchJJJonathan A. Javitch
- George LiapakisGLGeorge Liapakis
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 78 (4) , 785-793
Abstract
Family B of G protein-coupled receptors (GPCRs) is composed of receptors that bind peptides, such as secretin, glucagon, parathyroid hormone, and corticotropin releasing factor (CRF), which play critical physiological roles. These receptors, like all GPCRs, share a common structural motif of seven membrane-spanning segments, which have been proposed to bind small ligands, such as antalarmin, a nonpeptide antagonist of the type 1 receptor for CRF (CRF1). This leads to the hypothesis that as for family A GPCRs, the binding sites of small ligands for family B GPCRs are on the surface of a water-accessible crevice, the binding-site crevice, which is formed by the membrane-spanning segments and extends from the extracellular surface of the receptor into the plane of the membrane. To test this hypothesis we have begun to obtain structural information about family B GPCRs, using as a prototype the CRF1, by determining the ability of sulfhydryl-specific methanethiosulfonate derivatives, such as the methanethiosulfonate-ethylammonium (MTSEA), to react with CRF1 and thus irreversibly inhibit 125I-Tyr0-sauvagine binding. We found that MTSEA inhibited 125I-Tyr0-sauvagine binding to CRF1 and that antalarmin protected against this irreversible inhibition. To identify the susceptible cysteine(s), we mutated, one at a time, four endogenous cysteines to serine. Mutation to serine of Cys211, Cys233, or Cys364 decreased the susceptibility of sauvagine binding to irreversible inhibition by MTSEA. Thus, Cys211, Cys233, and Cys364 at the cytoplasmic ends of the third, fourth, and seventh membrane-spanning segments, respectively, are exposed in the binding site crevice of CRF1.Keywords
This publication has 46 references indexed in Scilit:
- Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 ReceptorJournal of Biological Chemistry, 2010
- Alanine Scanning Mutagenesis of the Second Extracellular Loop of Type 1 Corticotropin-Releasing Factor Receptor Revealed Residues Critical for Peptide BindingMolecular Pharmacology, 2009
- Residue 17 of Sauvagine Cross-links to the First Transmembrane Domain of Corticotropin-releasing Factor Receptor 1 (CRFR1)Journal of Biological Chemistry, 2008
- Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1Journal of Biological Chemistry, 2008
- Dopamine D2 receptors form higher order oligomers at physiological expression levelsThe EMBO Journal, 2008
- Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligandProceedings of the National Academy of Sciences, 2007
- Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled ReceptorsEndocrine Reviews, 2000
- Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin ReceptorJournal of Biological Chemistry, 1996
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995
- Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility methodNeuron, 1995